GlassScriptPhysician profile
Dennis M Britten
NPI 1982640876
$3,942.25
in general payments reported to CMS, 2019-2025
20 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $1,189 · 2021: $806 · 2022: $344 · 2023: $235 · 2024: $164 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,340.21 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $593.87 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $494.93 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $288.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.31 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $174.00 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $169.73 | 2019-2024 | Xarelto |
| Pfizer INC. | $142.12 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.14 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $83.36 | 2021-2023 | Verquvo |
| Inspire Medical Systems, INC. | $64.17 | 2025 | Inspire |
| Amgen INC. | $51.22 | 2020-2023 | Repatha |
| Ge Healthcare | $46.31 | 2020-2021 | |
| Novo Nordisk INC | $44.28 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $28.84 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.40 | 2021 | |
| Itamar Medical INC | $15.16 | 2023 | Watchpatone |
| Lexicon Pharmaceuticals, INC. | $14.98 | 2024 | |
| Cardiovascular Systems INC. | $14.88 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Britten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.